Modulation of HCV reinfection after orthotopic liver transplantation by fibroblast growth factor-2 and other non-interferon mediators
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Modulation of HCV reinfection after orthotopic liver transplantation by fibroblast growth factor-2 and other non-interferon mediators
Authors
Keywords
-
Journal
GUT
Volume 65, Issue 6, Pages 1015-1023
Publisher
BMJ
Online
2015-03-24
DOI
10.1136/gutjnl-2014-308003
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The clinically approved drugs amiodarone, dronedarone and verapamil inhibit filovirus cell entry
- (2014) Gerrit Gehring et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Fibroblast Growth Factor-2, Bone Homeostasis and Fracture Repair
- (2013) Yurong Fei et al. CURRENT PHARMACEUTICAL DESIGN
- Brivanib in Patients With Advanced Hepatocellular Carcinoma Who Were Intolerant to Sorafenib or for Whom Sorafenib Failed: Results From the Randomized Phase III BRISK-PS Study
- (2013) Josep M. Llovet et al. JOURNAL OF CLINICAL ONCOLOGY
- The AMPK-related kinase SNARK regulates hepatitis C virus replication and pathogenesis through enhancement of TGF-β signaling
- (2013) Kaku Goto et al. JOURNAL OF HEPATOLOGY
- Hepatocytes That Express Variants of Cyclophilin A Are Resistant to HCV Infection and Replication
- (2012) Thomas von Hahn et al. GASTROENTEROLOGY
- A Novel Monoclonal Antibody to Fibroblast Growth Factor 2 Effectively Inhibits Growth of Hepatocellular Carcinoma Xenografts
- (2012) L. Wang et al. MOLECULAR CANCER THERAPEUTICS
- Impact of Intra- and Interspecies Variation of Occludin on Its Function as Coreceptor for Authentic Hepatitis C Virus Particles
- (2011) S. Ciesek et al. JOURNAL OF VIROLOGY
- Serum cytokine profiles associated with early allograft dysfunction in patients undergoing liver transplantation
- (2011) Benjamin H. Friedman et al. LIVER TRANSPLANTATION
- EGFR and EphA2 are host factors for hepatitis C virus entry and possible targets for antiviral therapy
- (2011) Joachim Lupberger et al. NATURE MEDICINE
- Memory of fearful events: the role of fibroblast growth factor-2 in fear acquisition and extinction
- (2011) B.M. Graham et al. NEUROSCIENCE
- The Novel Immunosuppressive Protein Kinase C Inhibitor Sotrastaurin Has No Pro-Viral Effects on the Replication Cycle of Hepatitis B or C Virus
- (2011) Thomas von Hahn et al. PLoS One
- Development of Molecularly Targeted Therapies in Hepatocellular Carcinoma: Where Do We Go Now?
- (2010) R. S. Finn CLINICAL CANCER RESEARCH
- Evolving epidemiology of hepatitis C virus
- (2010) D. Lavanchy CLINICAL MICROBIOLOGY AND INFECTION
- Glucocorticosteroids Increase Cell Entry by Hepatitis C Virus
- (2010) Sandra Ciesek et al. GASTROENTEROLOGY
- Biological functions of the low and high molecular weight protein isoforms of fibroblast growth factor-2 in cardiovascular development and disease
- (2008) Siyun Liao et al. DEVELOPMENTAL DYNAMICS
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started